| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | LFM-A13 |
|---|
| Description | Purity >98% by NMR, TLC. LFM-A13 is a selective inhibitor of Bruton's tyrosine kinase (BTK) - IC50's = 2.5 uM (recombinant BTK) and 17.2 uM (human BTK). It has also been shown to inhibit Polo-like kinase (PLK) - IC50 = 61 uM for human PLK3. LFM-A13 displayed no activity (concentrations up to 278 uM) at JAK1, JAK3, HCK, EGFRK and IRK2 or CDK1-3, CHK1, IKK, MAPK1, SAPK2a and ten tyrosine kinases. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (2Z)-2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide |
|---|
| Gene, Accession, CAS # | CAS: 244240-24-2 |
|---|
| Catalog # | LS-H14736 |
|---|
| Price | |
|---|
| Order / More Info | LFM-A13 from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|